Jingrong Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jingrong Yang has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Alan S. Go
Kaiser Permanente Division of Research , Pleasanton, California
2 shared publications - Adrian F. Hernandez
Duke University School of Medicine, Durham, North Carolina, USA
1 shared publication - Anthony E. Steimle
Division of Research, Kaiser Permanente Northern California, Oakland
1 shared publication - Chiara Wabl
Kaiser Permanente Northern California
1 shared publication - Debbie L. Cohen
Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
1 shared publication - Eric Vittinghoff
Department of Epidemiology and Biostatistics, University of California, San Francisco , San Francisco, CA 94158
1 shared publication
Latest Publications
- Open Access
- 9 September 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Feasibility of a Novel Recurrence Algorithm to Improve NGS Testing in a Cohort of ER+/HER2- Metastatic Breast Cancer Patients in Kaiser Permanente Northern California
From the 6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy
- 9 September 2026
- Published by Binaytara in International Journal of Cancer Care and Delivery
- Vol. 6 (Supplement) , 1-2
Open AccessFeasibility of a Novel Recurrence Algorithm to Improve NGS Testing in a Cohort of ER+/HER2- Metastatic Breast Cancer Patients in Kaiser Permanente Northern California
From the 6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy
- 1 April 2016
- Published by Wolters Kluwer Health in Medical Care
- Vol. 54 (4) , 365-372
Post-discharge Follow-up Characteristics Associated With 30-Day Readmission After Heart Failure Hospitalization
Background: Readmission within 30 days after hospitalization for heart failure (HF) is a major public health problem. Objective: To examine whether timing and type of post-discharge follow-up impacts risk of 30-day readmission in adults hospitalized for HF. Design: Nested matched case-control study (January 1, 2006–June 30, 2013). Setting: A large, integrated health care delivery system in Northern California. Participants: Hospitalized adults with a primary diagnosis of HF discharged to home without hospice care. Measurements: Outpatient visits and telephone calls with cardiology and general medicine providers in non-emergency department and non-urgent care settings were counted as follow-up care. Statistical adjustments were made for differences in patient sociodemographic and clinical characteristics, acute severity of illness, hospitalization characteristics, and post-discharge medication changes and laboratory testing. Results: Among 11,985 eligible adults, early initial outpatient contact within 7 days after discharge was associated with lower odds of readmission [adjusted odds ratio (OR)=0.81; 95% CI, 0.70–0.94], whereas later outpatient contact between 8 and 30 days after hospital discharge was not significantly associated with readmission (adjusted OR=0.99; 95% CI, 0.82–1.19). Initial contact by telephone was associated with lower adjusted odds of 30-day readmission (adjusted OR=0.85; 95% CI, 0.69–1.06) but was not statistically significant. Conclusions: In adults discharged to home after hospitalization for HF, outpatient follow-up with a cardiology or general medicine provider within 7 days was associated with a lower chance of 30-day readmission.
- 1 April 2016
- Published by Wolters Kluwer Health in Medical Care
- Vol. 54 (4) , 365-372
Post-discharge Follow-up Characteristics Associated With 30-Day Readmission After Heart Failure Hospitalization
Background: Readmission within 30 days after hospitalization for heart failure (HF) is a major public health problem. Objective: To examine whether timing and type of post-discharge follow-up impacts risk of 30-day readmission in adults hospitalized for HF. Design: Nested matched case-control study (January 1, 2006–June 30, 2013). Setting: A large, integrated health care delivery system in Northern California. Participants: Hospitalized adults with a primary diagnosis of HF discharged to home without hospice care. Measurements: Outpatient visits and telephone calls with cardiology and general medicine providers in non-emergency department and non-urgent care settings were counted as follow-up care. Statistical adjustments were made for differences in patient sociodemographic and clinical characteristics, acute severity of illness, hospitalization characteristics, and post-discharge medication changes and laboratory testing. Results: Among 11,985 eligible adults, early initial outpatient contact within 7 days after discharge was associated with lower odds of readmission [adjusted odds ratio (OR)=0.81; 95% CI, 0.70–0.94], whereas later outpatient contact between 8 and 30 days after hospital discharge was not significantly associated with readmission (adjusted OR=0.99; 95% CI, 0.82–1.19). Initial contact by telephone was associated with lower adjusted odds of 30-day readmission (adjusted OR=0.85; 95% CI, 0.69–1.06) but was not statistically significant. Conclusions: In adults discharged to home after hospitalization for HF, outpatient follow-up with a cardiology or general medicine provider within 7 days was associated with a lower chance of 30-day readmission.
- Open Access
- 28 January 2016
- Published by Springer Nature in BMC Nephrology
- Vol. 17 (1) , 1-7
Anemia and risk for cognitive decline in chronic kidney disease
Anemia is common among patients with chronic kidney disease (CKD) but its health consequences are poorly defined. The aim of this study was to determine the relationship between anemia and cognitive decline in older adults with CKD. We studied a subgroup of 762 adults age ≥55 years with CKD participating in the Chronic Renal Insufficiency Cohort (CRIC) study. Anemia was defined according to the World Health Organization criteria (hemoglobin <13 g/dL for men and <12 g/dL for women). Cognitive function was assessed annually with a battery of six tests. We used logistic regression to determine the association between anemia and baseline cognitive impairment on each test, defined as a cognitive score more than one standard deviation from the mean, and mixed effects models to determine the relation between anemia and change in cognitive function during follow-up after adjustment for demographic and clinical characteristics. Of 762 participants with mean estimated glomerular filtration rate of 42.7 ± 16.4 ml/min/1.73 m2, 349 (46 %) had anemia. Anemia was not independently associated with baseline cognitive impairment on any test after adjustment for demographic and clinical characteristics. Over a median 2.9 (IQR 2.6–3.0) years of follow-up, there was no independent association between anemia and change in cognitive function on any of the six cognitive tests. Among older adults with CKD, anemia was not independently associated with baseline cognitive function or decline.
- 28 January 2016
- Published by Springer Nature in BMC Nephrology
- Vol. 17 (1) , 1-7
Open AccessAnemia and risk for cognitive decline in chronic kidney disease
Anemia is common among patients with chronic kidney disease (CKD) but its health consequences are poorly defined. The aim of this study was to determine the relationship between anemia and cognitive decline in older adults with CKD. We studied a subgroup of 762 adults age ≥55 years with CKD participating in the Chronic Renal Insufficiency Cohort (CRIC) study. Anemia was defined according to the World Health Organization criteria (hemoglobin <13 g/dL for men and <12 g/dL for women). Cognitive function was assessed annually with a battery of six tests. We used logistic regression to determine the association between anemia and baseline cognitive impairment on each test, defined as a cognitive score more than one standard deviation from the mean, and mixed effects models to determine the relation between anemia and change in cognitive function during follow-up after adjustment for demographic and clinical characteristics. Of 762 participants with mean estimated glomerular filtration rate of 42.7 ± 16.4 ml/min/1.73 m2, 349 (46 %) had anemia. Anemia was not independently associated with baseline cognitive impairment on any test after adjustment for demographic and clinical characteristics. Over a median 2.9 (IQR 2.6–3.0) years of follow-up, there was no independent association between anemia and change in cognitive function on any of the six cognitive tests. Among older adults with CKD, anemia was not independently associated with baseline cognitive function or decline.